Metabolically healthy obesity across the life course: epidemiology, determinants, and implications

Annals of the New York Academy of Sciences

Volumn 1391, Issue 1, 2017, Pages 85-100

  Phillips, Catherine M ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

definitions; determinants; life course; metabolically healthy obesity; personalized medicine; stability

Indexed keywords

ADOLESCENT DISEASE; ADULTHOOD; BODY COMPOSITION; CARDIORESPIRATORY FITNESS; CHILDHOOD OBESITY; DIET; GENETICS; HUMAN; LIFESTYLE; META ANALYSIS (TOPIC); METABOLICALLY HEALTHY OBESITY; OBESITY; PERSONALIZED MEDICINE; REVIEW; SOCIAL DETERMINANTS OF HEALTH; SYSTEMATIC REVIEW (TOPIC); BODY MASS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HEALTH STATUS; METABOLIC SYNDROME X; OBESITY, METABOLICALLY BENIGN; PATHOPHYSIOLOGY; RISK FACTOR;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HEALTH STATUS; HUMANS; METABOLIC SYNDROME X; OBESITY, METABOLICALLY BENIGN; RISK FACTORS;

EID: 84991045236     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.13230     Document Type: Review

References (126)

1. Non-Communicable Disease Risk Factor Collaboration. 2016. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387: 1377–1396.
2. Kelly, T., W. Yang, C.S. Chen, et al. 2008. Global burden of obesity in 2005 and projections to 2030. Int. J. Obes. 32: 1431–1437.
3. Keane, E., P.M. Kearney, I.J. Perry, et al. 2014. Trends and prevalence of overweight and obesity in primary school aged children in the Republic of Ireland from 2002–2012: a systematic review. BMC Public Health 14: 974.
4. Olds, T., C. Maher, S. Zumin, et al. 2011. Evidence that the prevalence of childhood overweight is plateauing: data from nine countries. Int. J. Pediatr. Obes. 6: 342–360.
5. Reilly, J.J. & J. Kelly. 2011. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int. J. Obes. (Lond.) 35: 891–898.
6. Dwyer, T., C. Sun, C.G. Magnussen, et al. 2013. Cohort profile: the international childhood cardiovascular cohort (i3C) consortium. Int. J. Epidemiol. 42: 86–96.
7. Franks, P.W., R.L. Hanson, W.C. Knowler, et al. 2010. Childhood obesity, other cardiovascular risk factors, and premature death. N. Engl. J. Med. 362: 485–493.
8. Charakida, M., A. Jones, E. Falaschetti, et al. 2012. Childhood obesity and vascular phenotypes: a population study. J. Am. Coll. Cardiol. 60: 2643–2650.
9. Liang, Y., D. Hou, X. Zhao, et al. 2015. Childhood obesity affects adult metabolic syndrome and diabetes. Endocrine 50: 87–92.
10. Raitakari, O.T., M. Juonala, M. Kahonen, et al. 2003. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290: 2277–2283.
11. Barker, D.J. 1995. Fetal origins of coronary heart disease. BMJ 311: 171–174.
12. Godfrey, K.M. & D.J. Barker. 2001. Fetal programming and adult health. Public Health Nutr. 4: 611–624.
13. Stefan, N., H.U. Haring, F.B. Hu, et al. 2016. Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications. Lancet Diabetes Endocrinol. 4: 457–467.
14. Camhi, S.M., M.E. Waring, S.B. Sisson, et al. 2013. Physical activity and screen time in metabolically healthy obese phenotypes in adolescents and adults. J. Obes. 2013: 984613.
15. Chun, S., S. Lee, H.J. Son, et al. 2015. Clinical characteristics and metabolic health status of obese Korean children and adolescents. Korean J. Fam. Med. 36: 233–238.
16. Li, S., W. Chen, S.R. Srinivasan, et al. 2012. Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study. Am. J. Epidemiol. 176(Suppl. 7): S142–S149.
17. Prince, R.L., J.L. Kuk, K.A. Ambler, et al. 2014. Predictors of metabolically healthy obesity in children. Diabetes Care 37: 1462–1468.
18. Vukovic, R., T. Milenkovic, K. Mitrovic, et al. 2015. Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents. Eur. J. Pediatr. 174: 1649–1655.
19. Vukovic, R., K. Mitrovic, T. Milenkovic, et al. 2013. Insulin-sensitive obese children display a favorable metabolic profile. Eur. J. Pediatr. 172: 201–206.
20. Zamrazilova, H., R. Weiss, V. Hainer, et al. 2016. Cardiometabolic health in obese adolescents is related to length of obesity exposure: a pilot study. J. Clin. Endocrinol. Metab. 101: 3088–3095.
21. Camhi, S.M., E. Whitney Evans, L.L. Hayman, et al. 2015. Healthy eating index and metabolically healthy obesity in U.S. adolescents and adults. Prev. Med. 77: 23–27.
22. Bluher, S. & P. Schwarz. 2014. Metabolically healthy obesity from childhood to adulthood—does weight status alone matter? Metabolism 63: 1084–1092.
23. Bouhours-Nouet, N., S. Dufresne, F.B. de Casson, et al. 2008. High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects? Diabetes Care 31: 1031–1036.
24. Mangge, H., S. Zelzer, P. Puerstner, et al. 2013. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity (Silver Spring) 21: E71–E77.
25. Pacifico, L., E. Poggiogalle, F. Costantino, et al. 2009. Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome. Eur. J. Endocrinol. 161: 861–870.
26. Reinehr, T., B. Wolters, C. Knop, et al. 2015. Strong effect of pubertal status on metabolic health in obese children: a longitudinal study. J. Clin. Endocrinol. Metab. 100: 301–308.
27. Senechal, M., B. Wicklow, K. Wittmeier, et al. 2013. Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese youth. Pediatrics 132: e85–e92.
28. Weghuber, D., S. Zelzer, I. Stelzer, et al. 2013. High risk vs. “metabolically healthy” phenotype in juvenile obesity—neck subcutaneous adipose tissue and serum uric acid are clinically relevant. Exp. Clin. Endocrinol. Diabetes 121: 384–390.
29. Howe, L.D., E. Zimmermann, R. Weiss, et al. 2014. Do rapid BMI growth in childhood and early-onset obesity offer cardiometabolic protection to obese adults in mid-life? Analysis of a longitudinal cohort study of Danish men. BMJ Open 4: e004827.
30. Li, L., J. Yin, H. Cheng, et al. 2016. Identification of genetic and environmental factors predicting metabolically healthy obesity in children: data from the BCAMS study. J. Clin. Endocrinol. Metab. 101: 1816–1825.
31. Phillips, C.M. 2013. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev. Endocr. Metab. Disord. 14: 219–227.
32. Wildman, R.P., P. Muntner, K. Reynolds, et al. 2008. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med. 168: 1617–1624.
33. Karelis, A.D. & R. Rabasa-Lhoret. 2008. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab. 34: 183–184.
34. Karelis, A., M. Brochu & R. Rabasa-Lhoret. 2004. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 30: 569–572.
35. Meigs, J.B., P.W.F. Wilson, C.S. Fox, et al. 2006. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocr. Metab. 91: 2906–2912.
36. Aguilar-Salinas, C.A., E.G. Garcia, L. Robles, et al. 2008. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J. Clin. Endocr. Metab. 93: 4075–4079.
37. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486–2497.
38. van Vliet-Ostaptchouk, J.V., M.L. Nuotio, S.N. Slagter, et al. 2014. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr. Disord. 14: 9.
39. Phillips, C.M., C. Dillon, J.M. Harrington, et al. 2013. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One 8: e76188.
40. Velho, S., F. Paccaud, G. Waeber, et al. 2010. Metabolically healthy obesity: different prevalences using different criteria. Eur. J. Clin. Nutr. 64: 1043–1051.
41. Yoo, H.K., E.Y. Choi, E.W. Park, et al. 2013. Comparison of metabolic characteristics of metabolically healthy but obese (MHO) middle-aged men according to different criteria. Korean J. Fam. Med. 34: 19–26.
42. Gomez-Ambrosi, J., C. Silva, J.C. Galofre, et al. 2012. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int. J. Obes. 36: 286–294.
43. Shea, J.L., E.W. Randell & G. Sun. 2011. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring) 19: 624–630.
44. Millar, S.R., I.J. Perry & C.M. Phillips. 2015. Assessing cardiometabolic risk in middle-aged adults using body mass index and waist–height ratio: are two indices better than one? A cross-sectional study. Diabetol. Metab. Syndr. 7: 73.
45. Phillips, C.M., A.C. Tierney, P. Perez-Martinez, et al. 2013. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype. Obesity (Silver Spring) 21: E154–E161.
46. Wang, B., R. Zhuang, X. Luo, et al. 2015. Prevalence of metabolically healthy obese and metabolically obese but normal weight in adults worldwide: a meta-analysis. Horm. Metab. Res. 47: 839–845.
47. Stefan, N., H.U. Haring, F.B. Hu, et al. 2013. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 1: 152–162.
48. Stefan, N., K. Kantartzis, J. Machann, et al. 2008. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168: 1609–1616.
49. Arsenault, B.J., D. Lachance, I. Lemieux, et al. 2007. Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch. Intern. Med. 167: 1518–1525.
50. Despres, J.P. & I. Lemieux. 2006. Abdominal obesity and metabolic syndrome. Nature 444: 881–887.
51. Shulman, G.I. 2014. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 371: 2237–2238.
52. Adiels, M., M.R. Taskinen, C. Packard, et al. 2006. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49: 755–765.
53. Despres, J.P. 1998. The insulin resistance–dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obes. Res. 6(Suppl. 1): 8S–17S.
54. Hwang, J.H., D.T. Stein, N. Barzilai, et al. 2007. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am. J. Physiol. Endocrinol. Metab. 293: E1663–E1669.
55. Jakobsen, M.U., T. Berentzen, T.I. Sorensen, et al. 2007. Abdominal obesity and fatty liver. Epidemiol. Rev. 29: 77–87.
56. Korenblat, K.M., E. Fabbrini, B.S. Mohammed, et al. 2008. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134: 1369–1375.
57. Chang, Y., H.S. Jung, J. Cho, et al. 2016. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am. J. Gastroenterol. 111: 1133–1140.
58. Heianza, Y., Y. Arase, H. Tsuji, et al. 2014. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). J. Clin. Endocrinol. Metab. 99: 2952–2960.
59. Jung, C.H., Y.M. Kang, J.E. Jang, et al. 2016. Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity. Obesity (Silver Spring) 24: 1373–1379.
60. Sung, K.C., S.C. Cha, J.W. Sung, et al. 2014. Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis. Nutr. Metab. Cardiovasc. Dis. 24: 256–262.
61. Zhang, H., Z. Ma, L. Pan, et al. 2016. Hepatic fat content is a determinant of metabolic phenotypes and increased carotid intima-media thickness in obese adults. Sci. Rep. 6: 21894.
62. McMorrow, A.M., R.M. Connaughton, F.E. Lithander, et al. 2015. Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: potential impact of dietary fat quality. Proc. Nutr. Soc. 74: 67–82.
63. Kloting, N., M. Fasshauer, A. Dietrich, et al. 2010. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 299: E506–E515.
64. O'Connell, J., L. Lynch, A. Hogan, et al. 2011. Preadipocyte factor-1 is associated with metabolic profile in severe obesity. J. Clin. Endocrinol. Metab. 96: E680–E684.
65. Phillips, C.M. & I.J. Perry. 2013. Does inflammation determine metabolic health status in obese and nonobese adults? J. Clin. Endocrinol. Metab. 98: E1610–E1619.
66. Stienstra, R. & N. Stefan. 2013. Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. Diabetologia 56: 2343–2346.
67. Després, J.P. 2012. Body fat distribution and risk of cardiovascular disease: an Update. Circulation 126: 1301–1313.
68. Linder, K., F. Springer, J. Machann, et al. 2014. Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity (Silver Spring) 22: 1325–1331.
69. Fabbrini, E., F. Magkos, B.S. Mohammed, et al. 2009. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U.S.A. 106: 15430–15435.
70. Fabbrini, E., J. Yoshino, M. Yoshino, et al. 2015. Metabolically normal obese people are protected from adverse effects following weight gain. J. Clin. Invest. 125: 787–795.
71. Hankinson, A.L., M.L. Daviglus, L. Van Horn, et al. 2012. Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring) 21: 637–643.
72. Kimokoti, R.W., S.E. Judd, J.M. Shikany, et al. 2015. Metabolically healthy obesity is not associated with food intake in white or black men. J. Nutr. 145: 2551–2561.
73. Manu, P., C. Ionescu-Tirgoviste, J. Tsang, et al. 2012. Dysmetabolic signals in “metabolically healthy” obesity. Obes. Res. Clin. Pract. 6: e9–e20.
74. Bell, L.K., S. Edwards & J.A. Grieger. 2015. The relationship between dietary patterns and metabolic health in a representative sample of adult Australians. Nutrient 7: 6491–6505.
75. Park, Y.M., S.E. Steck, T.T. Fung, et al. 2016. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes. Int. J. Obes. doi: 10.1038/ijo.2016.114.
76. Janiszewski, P.M. & R. Ross. 2010. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 33: 1957–1959.
77. Kantartzis, K., J. Machann, F. Schick, et al. 2011. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 54: 864–868.
78. Karelis, A.D., V. Messier, M. Brochu, et al. 2008. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 51: 1752–1754.
79. Shin, M.J., Y.J. Hyun, O.Y. Kim, et al. 2006. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int. J. Obes. 30: 1529–1534.
80. Rondanelli, M., C. Klersy, S. Perna, et al. 2015. Effects of two-months balanced diet in metabolically healthy obesity: lipid correlations with gender and BMI-related differences. Lipids Health Dis. 14: 139.
81. Ruiz, J.R., F.B. Ortega & I. Labayen. 2013. A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese and metabolically healthy but obese premenopausal women. Ann. Nutr. Metab. 62: 223–230.
82. Liu, R.H., S. Wharton, A.M. Sharma, et al. 2013. Influence of a clinical lifestyle-based weight loss program on the metabolic risk profile of metabolically normal and abnormal obese adults. Obesity (Silver Spring) 21: 1533–1539.
83. Hogstrom, G., A. Nordstrom & P. Nordstrom. 2014. High aerobic fitness in late adolescence is associated with a reduced risk of myocardial infarction later in life: a nationwide cohort study in men. Eur. Heart J. 35: 3133–3140.
84. Kodama, S., K. Saito, S. Tanaka, et al. 2009. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301: 2024–2035.
85. Myers, J., P. McAuley, C.J. Lavie, et al. 2015. Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. Prog. Cardiovasc. Dis. 57: 306–314.
86. Sato, M., S. Kodama, A. Sugawara, et al. 2009. Physical fitness during adolescence and adult mortality. Epidemiology 20: 463–464.
87. Dalleck, L.C., G.P. Van Guilder, T.B. Richardson, et al. 2014. A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype. Diabetes Metab. Syndr. Obes. 7: 369–380.
88. Ortega, F.B., D.C. Lee, P.T. Katzmarzyk, et al. 2013. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur. Heart J. 34: 389–397.
89. Ortega, F.B., C. Cadenas-Sanchez, X. Sui, et al. 2015. Role of fitness in the metabolically healthy but obese phenotype: a review and update. Prog. Cardiovasc. Dis. 58: 76–86.
90. Berezina, A., O. Belyaeva, O. Berkovich, et al. 2015. Prevalence, risk factors, and genetic traits in metabolically healthy and unhealthy obese individuals. Biomed. Res. Int. 2015: 548734.
91. Ferguson, J.F., C.M. Phillips, A.C. Tierney, et al. 2010. Gene–nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am. J. Clin. Nutr. 91: 794–801.
92. Phillips, C.M., L. Goumidi, S. Bertrais, et al. 2010. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J. Nutr. 140: 238–244.
93. Kvaloy, K., J. Holmen, K. Hveem, et al. 2015. Genetic effects on longitudinal changes from healthy to adverse weight and metabolic status—the HUNT study. PLoS One 10: e0139632.
94. Appleton, S.L., C.J. Seaborn, R. Visvanathan, et al. 2013. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 36: 2388–2394.
95. Soriguer, F., C. Gutierrez-Repiso, E. Rubio-Martin, et al. 2013. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J. Clin. Endocrinol. Metab. 98: 2318–2325.
96. Eshtiaghi, R., S. Keihani, F. Hosseinpanah, et al. 2015. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study. Int. J. Obes. 39: 514–519.
97. Hamer, M., J.A. Bell, S. Sabia, et al. 2015. Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. Eur. J. Endocrinol. 173: 703–708.
98. Achilike, I., H.P. Hazuda, S.P. Fowler, et al. 2015. Predicting the development of the metabolically healthy obese phenotype. Int. J. Obes. 39: 228–234.
99. Flegal, K.M., B.K. Kit, H. Orpana, et al. 2013. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309: 71–82.
100. Benckert, M., M. Lilja, S. Soderberg, et al. 2015. Improved metabolic health among the obese in six population surveys 1986 to 2009: the Northern Sweden MONICA study. BMC Obes. 2: 7.
101. Hamer, M. & E. Stamatakis. 2012. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 97: 2482–2488.
102. Guo, F. & W.T. Garvey. 2015. Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: stability of metabolic health status in adults. Obesity (Silver Spring) 22: 2420–2425.
103. Arnlov, J., J. Sundstrom, E. Ingelsson, et al. 2011. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 34: 61–65.
104. Calori, G., G. Lattuada, L. Piemonti, et al. 2011. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34: 210–215.
105. Durward, C.M., T.J. Hartman & S.M. Nickols-Richardson. 2012. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J. Obes. 2012: 460321.
106. Hinnouho, G.M., S. Czernichow, A. Dugravot, et al. 2013. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 36: 2294–2300.
107. Kuk, J.L. & C.I. Ardern. 2009. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32: 2297–2299.
108. van der, A.D., A.C. Nooyens, F.J. van Duijnhoven, et al. 2013. All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPIC-MORGEN study. Obesity (Silver Spring) 22: 557–564.
109. Bradshaw, P.T. & J. Stevens. 2015. Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype. Am. J. Epidemiol. 182: 742–744.
110. Phillips, C.M. 2016. Metabolically healthy obesity: personalised and public health implications. Trends Endocrinol. Metab. 27: 189–191.
111. Puri, R. 2014. Is it finally time to dispel the concept of metabolically-healthy obesity? J. Am. Coll. Cardiol. 63: 2687–2688.
112. Rey-Lopez, J.P., L.F. de Rezende, T.H. de Sa, et al. 2015. Is the metabolically healthy obesity phenotype an irrelevant artifact for public health? Am. J. Epidemiol. 182: 737–741.
113. Hinnouho, G.M., S. Czernichow, A. Dugravot, et al. 2015. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur. Heart J. 36: 551–559.
114. Khan, U.I., D. Wang, R.C. Thurston, et al. 2011. Burden of subclinical cardiovascular disease in “metabolically benign” and “at-risk” overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Atherosclerosis 217: 179–186.
115. Kwon, B.J., D.W. Kim, S.H. Her, et al. 2013. Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease. Metabolism 62: 952–960.
116. McPherson, K., K.P., B. Butland, S. Jebb, et al. 2007. Tackling Obesities: Future Choices—Project Report. 2nd ed. Governemnt Office for Science.
117. Bosello, O., M.P. Donataccio & M. Cuzzolaro. 2016. Obesity or obesities? Controversies on the association between body mass index and premature mortality. Eat. Weight Disord. 21: 165–174.
118. Munoz-Garach, A., I. Cornejo-Pareja & F.J. Tinahones. 2016. Does metabolically healthy obesity exist? Nutrients 8. pii: E320. DOI: 10.3390/nu8060320.
119. Payab, M., S. Hasani-Ranjbar & B. Larijani. 2014. Whether all obese subjects both in metabolic groups and non-metabolic groups should be treated or not. J. Diabetes Metab. Disord. 13: 21.
120. de Rooij, B.H., J.D. van der Berg, C.J. van der Kallen, et al. 2016. Physical activity and sedentary behavior in metabolically healthy versus unhealthy obese and non-obese individuals—the Maastricht study. PLoS One 11: e0154358.
121. Schroder, H., R. Ramos, J.M. Baena-Diez, et al. 2014. Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population. Eur. J. Nutr. 53: 1345–1353.
122. Doumatey, A.P., J. Zhou, M. Zhou, et al. 2016. Proinflammatory and lipid biomarkers mediate metabolically healthy obesity: a proteomics study. Obesity (Silver Spring) 24: 1257–1265.
123. Phillips, C.M. & I.J. Perry. 2015. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter? Atherosclerosis 242: 399–406.
124. Garvey, W.T., A.J. Garber, J.I. Mechanick, et al. 2014. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease. Endocr. Pract. 20: 977–989.
125. Garvey, W.T., J.I. Mechanick, E.M. Brett, et al. 2016. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity. Endocr. Pract. 22: 842–884.
126. Phillips, C.M. & I.J. Perry. 2015. Depressive symptoms, anxiety and well-being among metabolic health obese subtypes. Psychoneuroendocrinology 62: 47–53.